Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,702,557
-$636,350 QoQ
Shares Held
13,476
-19.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#886
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $207,269,806 across 16 Drug Manufacturers - General names. GILD ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
55,467 | $66,528,789 | |
| 2 | JNJ |
Johnson & Johnson
|
234,177 | $59,473,932 | |
| 3 | ABBV |
AbbVie Inc.
|
111,021 | $27,937,324 | |
| 4 | AMGN |
Amgen Inc
|
40,211 | $14,561,207 | |
| 5 | MRK |
Merck & Co., Inc.
|
112,376 | $14,440,316 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
128,389 | $7,397,774 | |
| 7 | PFE |
Pfizer Inc
|
197,145 | $4,747,251 | |
| 8 | NVS |
Novartis AG
|
25,239 | $3,955,456 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,702,557 | 13,476 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,338,907 | 16,782 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $436,217 | 3,554 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $402,042 | 3,622 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $572,200 | 5,161 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $334,581 | 2,986 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $248,844 | 2,694 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $261,748 | 3,122 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $220,032 | 3,207 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $234,546 | 3,202 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $264,011 | 3,259 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $248,426 | 3,315 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $214,100 | 2,778 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $238,870 | 2,879 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $206,297 | 2,403 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $171,313 | 2,777 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $141,544 | 2,290 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $128,114 | 2,155 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $77,692 | 1,070 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $464,223 | 6,646 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $444,147 | 6,450 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $408,396 | 6,319 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $391,798 | 6,725 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $391,714 | 6,199 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $500,956 | 6,511 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $65,788 | 880 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||